4//SEC Filing
Schultes Birgit C 4
Accession 0001193125-26-006292
CIK 0001652130other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:05 PM ET
Size
5.0 KB
Accession
0001193125-26-006292
Insider Transaction Report
Form 4
Schultes Birgit C
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2026-01-05$9.21/sh−8,508$78,359→ 98,533 total
Footnotes (2)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
- [F2]Includes 925 and 932 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0002051419
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:05 PM ET
- Size
- 5.0 KB